Skip to content

PRIMIX BIO VENTURES

Active
Private limited companyfounded 2002active for 24 yearsKlein Vilvoordestraat 8, 3078 Kortenberg, BelgiumKBO/BCE: BE 0476.755.691

From the official registers: KBO 23 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

PRIMIX BIO VENTURES has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €1.2m and a net result of €106,274. Equity has been growing by about 10% per year since 2018. Its solvency ranks better than 92% of 271 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.1% (very low).

Overview

Official details

KBO
Status
Active since 25-01-2002 Normal situation
Legal form
Private limited company
Registered office
Klein Vilvoordestraat 8, 3078 Kortenberg
Activity
Other research and development on natural sciences NACE 72109
Establishment unit
2.101.573.690 3078 Kortenberg, since 20-02-2002
Financial year end
31 December
Peppol
Reachable since 01-12-2025

Board and ownership

Board

Financial position

95 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.1%
Annual accounts 2025
Gross margin
€172,266
▼ 31.2%
Turnover
≈ €440,000
estimated
Profit
€106,274
▼ 45.6%
Equity
€1.2m
▲ 9.6%
Total assets
€1.3m
▲ 8.7%
2025 accounts filed on time
Filed on 31-07-2026at the National Bank
Score breakdownraises risk1 of the last 3 accounts latelowers riskSize: total assets €1.3mEquity €1.2m (94.9% of total assets)Founded in 2002Show the evidence

Checked score

Score 2025
95 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 61% of micro companies in research and development (NACE 72)
Financial strength · tick: 2024
Strong
Solvency 100=
equity 94.9% of total assets
Liquidity 59-39
short-term debt 4.9% · cash 7.3%
Profitability 79-10
return on assets 8.3%
Bankruptcy probability within 12 months
0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (935 companies, NACE 72, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.2%▲ +0.1 percentage points vs 11-2024 01-2025: 0.1%▼ -0.1 percentage points vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.2%▲ +0.1 percentage points vs 02-2025 04-2025: 0.1%▼ -0.1 percentage points vs 03-2025 05-2025: 0.1%● unchanged vs 04-2025 06-2025: 0.1%● unchanged vs 05-2025 07-2025: 0.1%● unchanged vs 06-2025 08-2025: 0.2%▲ +0.1 percentage points vs 07-2025highest value 09-2025: < 0.1%▼ -0.2 percentage points vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: 0.1%▲ +0.1 percentage points vs 07-2026 09-2026: 0.1%● unchanged vs 08-2026 10-2026: 0.1%● unchanged vs 09-2026
Credit of up to €110,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 17.86 (17.39 in 2024), above the usual 1.5. Short-term debt is 4.9% and cash 7.3% of total assets. 5.1% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 72, micro). It does better than 83% of them on solvency, 48% on liquidity, 54% on profitability and 61% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Five signals.
lowers riskraises riskneutral
raises risk · 1 of the last 3 accounts late
NBB · filings
lowers risk · Size: total assets €1.3m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Equity €1.2m (94.9% of total assets)
NBB · annual accounts
lowers risk · Founded in 2002
Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.
KBO
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-07-2026, 0 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
on the day
2024
29 days late
2023
117 days late
2022
31 days late
2021
31 days late
2020
19 days early
2019
58 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 19 days after the deadline. In the sector (NACE 72), the median for financial year 2024 was 13 days before the deadline, and 32% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 filed years within 31 days of that day).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher solvency than 92% of companies in research and developmentsector median 45.5% · 271 companies 94.9% View
  • Caution: Result fell in 2025from €195,337 to €106,274 ▼ 45.6% View
  • Positive: 8 profitable years in a rowprofit 2025: €106,274 8 years View

Documents

Annual accounts at the NBB

All 23 annual accounts

Articles and registers

Key facts about PRIMIX BIO VENTURES

What is the company number of PRIMIX BIO VENTURES?
The company number of PRIMIX BIO VENTURES is 0476.755.691. The VAT number is the same number with BE in front: BE 0476.755.691.
Where is PRIMIX BIO VENTURES based?
The registered office is at Klein Vilvoordestraat 8, 3078 Kortenberg.Company details
What does PRIMIX BIO VENTURES do?
According to the KBO register, the main activity is other research and development on natural sciences (NACE 72109).
What is the legal form of PRIMIX BIO VENTURES?
The legal form of PRIMIX BIO VENTURES is Private limited company (BV).
When was PRIMIX BIO VENTURES founded?
PRIMIX BIO VENTURES was founded on 25-01-2002.
Is PRIMIX BIO VENTURES still active?
Yes, PRIMIX BIO VENTURES is an active enterprise in the KBO register.
What is the turnover of PRIMIX BIO VENTURES?
The turnover in financial year 2025 is ≈ €440,000. This figure is estimated from the gross margin of €172,266 and 1,644 comparable companies of the same size. It probably lies between €270,000 and €820,000. It is a rough estimate.Financials
Is PRIMIX BIO VENTURES profitable?
In financial year 2025, PRIMIX BIO VENTURES made a profit of €106,274.
Where can I find the annual accounts of PRIMIX BIO VENTURES?
PRIMIX BIO VENTURES filed 23 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of PRIMIX BIO VENTURES due?
PRIMIX BIO VENTURES must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Comparable companies

These companies have the same main activity as PRIMIX BIO VENTURES: other research and development on natural sciences (NACE 72109). They are comparable in size and age: total assets between €872,000 and €1.4m, founded between 1999 and 2005.

CompanyTotal assetsGross margin
PRIMIX BIO VENTURES Kortenberg€1.3m€0.2m
Dokter Alexandra Keersmaekers Mol€1.4m€0.1m
DR. DEVLEESCHOUWER DIRK Brakel€1.1m€0.2m
MIXY Herentals€1.0m€0.2m
Automation Control Electronics Eghezée€1.0m€0.1m
DR. PEETERMANS ELS , OOGHEELKUNDE Pajottegem€0.9m€0.2m
Clinical Trials Claeys Oud-Heverlee€0.9m€0.2m
Full comparison

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.